E-ISSN 2146-8133
 

Review Article 


A Review of the Prevention and Treatment of Hypertrophic Scars: Part II. Experimental Studies

Huseyin Karagoz, Yalcin Bayram, Celalettin Sever, Cihan Sahin, Yalcin Kulahci, Ersin Ulkur.

Cited by (3)

Abstract
The understanding of the pathophysiological events of wound healing is very important to carry out the prevention or treatment of hypertrophic scars. Wound healing is a complex process consisting of the overlapping events, and the researchers have focused on the pathophysiology of the scar formation. The purpose of this article is to review the recent experimental studies about hypertrophic scars, and to analyze the substances focused on by recent experimental studies.
We analyzed the researches for new hopeful treatment modalities as well as the substances that are important to wound healing in the second part of this extensive review. The researchers have tried to find a way to scarless wound healing, and it seems likely that new therapies will be available within the next few years.

Key words: Experimental studies, hypertrophic scar, prevention, treatment


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Huseyin Karagoz
Articles by Yalcin Bayram
Articles by Celalettin Sever
Articles by Cihan Sahin
Articles by Yalcin Kulahci
Articles by Ersin Ulkur
on Google
on Google Scholar
Article Statistics
 Viewed: 4330
Downloaded: 753
Cited: 3

REFERENCES
1. Fumagalli M, Musso T, Vermi W, Scutera S, Daniele R, Alotto D, et al. Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin. Exp Dermatol 2007;16:600-610.

http://dx.doi.org/10.1111/j.1600-0625.2007.00571.x

[Pubmed]   

2. Atiyeh BS. Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg 2007;31:468-492.

http://dx.doi.org/10.1007/s00266-006-0253-y

[
Pubmed]   

3. Hsu, A, Mustoe TA. The Principles of Wound Healing. In: Weinzweig J (ed). Plastic Surgery Secrets, Mosby Elsevier, China, 2010;1-43.

http://dx.doi.org/10.1016/B978-0-323-03470-8.00001-6


4. Broughton G 2nd, Rohrich RJ. Wounds and Scars. Selected Readings in Plastic Surgery, Volume 10, number 7, part I, 2005;5-7.


5. Bailey AJ, Bazin S, Sims TJ, Le Lous M, Nicoletis C, Delaunay A. Characterization of the collagen of human hypertrophic and normal scars. Biochim Biophys Acta 1975;405:412-421.

http://dx.doi.org/10.1016/0005-2795(75)90106-3


6. Oliveira GV, Hawkins HK, Chinkes D, Burke A, Tavares AL, Ramos-e-Silva M, et. al. Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens. Int Wound J 2009;6:445-452.

http://dx.doi.org/10.1111/j.1742-481X.2009.00638.x

[
Pubmed]   

7. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108 (Pt 3):985-1002.

[
Pubmed]   

8. Karagoz H, Sever C, Bayram Y, Sahin C, Kulahci Y, Ulkur E. A Review of the Prevention and Treatment of Hypertrophic Scars: Part I Clinical Aspects. Arch Clin Exp Surg 2012 May 28. [DOI via Crossref]    [Epub ahead of print].

http://dx.doi.org/10.5455/aces.20120218124923


9. Chen YG, Lui HM, Lin SL, Lee JM, Ying SY. Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood) 2002;227:75-87.


10. Sulyok S, Wankell M, Alzheimer C, Werner S. Activin: an important regulator of wound repair, fibrosis, and neuroprotection. Mol Cell Endocrinol 2004;225:127-132.

http://dx.doi.org/10.1016/j.mce.2004.07.011

[
Pubmed]   

11. Jones KL, de Kretser DM, Patella S, Phillips DJ. Activin A and follistatin in systemic inflammation. Mol Cell Endocrinol 2004;225:119-125.

http://dx.doi.org/10.1016/j.mce.2004.07.010

[
Pubmed]   

12. Hübner G, Hu Q, Smola H, Werner S. Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev Biol 1996;173:490-498.

http://dx.doi.org/10.1006/dbio.1996.0042

[
Pubmed]   

13. Hübner G, Werner S. Serum growth factors and proinflammatory cytokines are potent inducers of activin expression in cultured fibroblasts and keratinocytes. Exp Cell Res 1996;228:106-113.

http://dx.doi.org/10.1006/excr.1996.0305

[
Pubmed]   

14. Matsuse T, Ikegami A, Ohga E, Hosoi T, Oka T, Kida K, et al. Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis. Am J Pathol 1996;148:707-713.

[
Pubmed]    [PMC Free Fulltext]   

15. Yamashita S, Maeshima A, Kojima I, Nojima Y. Activin A is a potent activator of renal interstitial fibroblasts. J Am Soc Nephrol 2004;15:91-101.

http://dx.doi.org/10.1097/01.ASN.0000103225.68136.E6

[
Pubmed]   

16. Hübner G, Brauchle M, Gregor M, Werner S. Activin A: a novel player and inflammatory marker in inflammatory bowel disease? Lab Invest 1997;77:311-318.

[
Pubmed]   

17. Gribi R, Tanaka T, Harper-Summers R, Yu J. Expression of activin A in inflammatory arthropathies. Mol Cell Endocrinol 2001;180:163-167.

http://dx.doi.org/10.1016/S0303-7207(01)00517-2


18. Ohnishi N, Miyata T, Ohnishi H, Yasuda H, Tamada K, Ueda N, et al. Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis. Gut 2003;52:1487-1493.

http://dx.doi.org/10.1136/gut.52.10.1487

[
Pubmed]    [PMC Free Fulltext]   

19. Sugiyama M, Ichida T, Sato T, Ishikawa T, Matsuda Y, Asakura H. Expression of activin A is increased in cirrhotic and fibrotic rat livers. Gastroenterology 1998;114:550-558.

http://dx.doi.org/10.1016/S0016-5085(98)70539-6


20. de Caestecker M. The transforming growth factor-beta superfamily of receptors. Cytokine Growth Factor Rev 2004;15:1-11.

http://dx.doi.org/10.1016/j.cytogfr.2003.10.004

[
Pubmed]   

21. Kretzschmar M, Massagué J. SMADs: mediators and regulators of TGF-beta signaling. Curr Opin Genet Dev 1998;8:103-111.

http://dx.doi.org/10.1016/S0959-437X(98)80069-5


22. Sugino K, Kurosawa N, Nakamura T, Takio K, Shimasaki S, Ling N, et al. Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell. J Biol Chem 1993;268:15579-15587.

[
Pubmed]   

23. Phillips DJ, de Kretser DM. Follistatin: a multifunctional regulatory protein. Front Neuroendocrinol 1998;19:287-322.

http://dx.doi.org/10.1006/frne.1998.0169

[
Pubmed]   

24. Munz B, Smola H, Engelhardt F, Bleuel K, Brauchle M, Lein I, et al. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J 1999;18:5205-5215.

http://dx.doi.org/10.1093/emboj/18.19.5205

[
Pubmed]    [PMC Free Fulltext]   

25. Wankell M, Munz B, Hübner G, Hans W, Wolf E, Goppelt A, et al. Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis. EMBO J 2001;20:5361-5372.

http://dx.doi.org/10.1093/emboj/20.19.5361

[
Pubmed]    [PMC Free Fulltext]   

26. Mukhopadhyay A, Chan SY, Lim IJ, Phillips DJ, Phan TT. The role of the activin system in keloid pathogenesis. Am J Physiol Cell Physiol 2007;292:C1331-1338.

http://dx.doi.org/10.1152/ajpcell.00373.2006

[
Pubmed]   

27. Ghahary A, Shen YJ, Scott PG, Gong Y, Tredget EE. Enhanced expression of mRNA for transforming growth factor-beta, type I and type III procollagen in human post-burn hypertrophic scar tissues. J Lab Clin Med 1993;122:465-473.

[
Pubmed]   

28. Karagiannidis C, Hense G, Martin C, Epstein M, Rückert B, Mantel PY, et al. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma. J Allergy Clin Immunol 2006;117:111-118.

http://dx.doi.org/10.1016/j.jaci.2005.09.017

[
Pubmed]   

29. Harrison CA, Gray PC, Vale WW, Robertson DM. Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 2005;16:73-78.

http://dx.doi.org/10.1016/j.tem.2005.01.003

[
Pubmed]   

30. Aoki F, Kurabayashi M, Hasegawa Y, Kojima I. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Am J Respir Crit Care Med 2005;172:713-720.

http://dx.doi.org/10.1164/rccm.200412-1620OC

[
Pubmed]   

31. Dohi T, Ejima C, Kato R, Kawamura YI, Kawashima R, Mizutani N, et al. Therapeutic potential of follistatin for colonic inflammation in mice. Gastroenterology 2005;128:411-423.

http://dx.doi.org/10.1053/j.gastro.2004.11.063

[
Pubmed]   

32. Antsiferova M, Klatte JE, Bodó E, Paus R, Jorcano JL, Matzuk MM, et al. Keratinocyte-derived follistatin regulates epidermal homeostasis and wound repair. Lab Invest 2009;89:131-141.

http://dx.doi.org/10.1038/labinvest.2008.120

[
Pubmed]   

33. Liu W, Wu X, Gao Z. New potential antiscarring approaches. Wound Repair Regen 2011;19 Suppl 1:s22-31.

http://dx.doi.org/10.1111/j.1524-475X.2011.00710.x

[
Pubmed]   

34. Shah M, Foreman DM, Ferguson MW. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 1992;339:213-214.

http://dx.doi.org/10.1016/0140-6736(92)90009-R


35. Ferguson MW, Duncan J, Bond J, Bush J, Durani P, So K, et al. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies. Lancet 2009;373:1264-1274.

http://dx.doi.org/10.1016/S0140-6736(09)60322-6


36. Krummel TM, Michna BA, Thomas BL, Sporn MB, Nelson JM, Salzberg AM, et al. Transforming growth factor beta (TGF-beta) induces fibrosis in a fetal wound model. J Pediatr Surg 1988;23:647-652.

http://dx.doi.org/10.1016/S0022-3468(88)80638-9


37. Houghton PE, Keefer KA, Krummel TM. The role of transforming growth factor-beta in the conversion from "scarless" healing to healing with scar formation. Wound Repair Regen 1995;3:229-236.

http://dx.doi.org/10.1046/j.1524-475X.1995.30215.x

[
Pubmed]   

38. Honardoust D, Varkey M, Marcoux Y, Shankowsky HA, Tredget EE. Reduced decorin, fibromodulin, and transforming growth factor-β3 in deep dermis leads to hypertrophic scarring. J Burn Care Res 2012;33:218-227.

http://dx.doi.org/10.1097/BCR.0b013e3182335980

[
Pubmed]   

39. Shah M, Foreman DM, Ferguson MW. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 1994;107 (Pt 5):1137-1157.

[
Pubmed]   

40. Baisch A, Riedel F. [Hyperplastic scars and keloids. Part I: basics and prevention]. [Article in German] HNO 2006;54:893-904.

http://dx.doi.org/10.1007/s00106-006-1462-z

[
Pubmed]   

41. Katz BE. Silicone gel sheeting in scar therapy. Cutis 1995;56:65-67.

[
Pubmed]   

42. Berman B, Perez OA, Konda S, Kohut BE, Viera MH, Delgado S, et al. A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatol Surg 2007;33:1291-1302.

http://dx.doi.org/10.1111/j.1524-4725.2007.33280.x

[
Pubmed]   

43. Li-Tsang CW, Lau JC, Choi J, Chan CC, Jianan L. A prospective randomized clinical trial to investigate the effect of silicone gel sheeting (Cica-Care) on post-traumatic hypertrophic scar among the Chinese population. Burns 2006;32:678-683.

http://dx.doi.org/10.1016/j.burns.2006.01.016

[
Pubmed]   

44. Gold MH, Foster TD, Adair MA, Burlison K, Lewis T. Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol Surg 2001;27:641-644.

http://dx.doi.org/10.1046/j.1524-4725.2001.00356.x

[
Pubmed]   

45. Occleston NL, O'Kane S, Laverty HG, Cooper M, Fairlamb D, Mason T, et al. Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring. Wound Repair Regen 2011;19 Suppl 1:s38-48.

http://dx.doi.org/10.1111/j.1524-475X.2011.00711.x

[
Pubmed]   

46. O'Kane S, Ferguson MW. Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 1997;29:63-78.

http://dx.doi.org/10.1016/S1357-2725(96)00120-3


47. Lin RY, Sullivan KM, Argenta PA, Meuli M, Lorenz HP, Adzick NS. Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair. Ann Surg 1995;222:146-154.

http://dx.doi.org/10.1097/00000658-199508000-00006

[
Pubmed]    [PMC Free Fulltext]   

48. Occleston NL, Laverty HG, O'Kane S, Ferguson MW. Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical. J Biomater Sci Polym Ed 2008;19:1047-1063.

http://dx.doi.org/10.1163/156856208784909345

[
Pubmed]   

49. Irwin CR, Picardo M, Ellis I, Sloan P, Grey A, McGurk M, et al. Inter- and intra-site heterogeneity in the expression of fetal-like phenotypic characteristics by gingival fibroblasts: potential significance for wound healing. J Cell Sci 1994;107 (Pt 5):1333-1346.

[
Pubmed]   

50. Schrementi ME, Ferreira AM, Zender C, DiPietro LA. Site-specific production of TGF-beta in oral mucosal and cutaneous wounds. Wound Repair Regen 2008;16:80-86.

http://dx.doi.org/10.1111/j.1524-475X.2007.00320.x

[
Pubmed]   

51. Mustoe TA, Gurjala A. The role of the epidermis and the mechanism of action of occlusive dressings in scarring. Wound Repair Regen 2011;19 Suppl 1:s16-21.

http://dx.doi.org/10.1111/j.1524-475X.2011.00709.x

[
Pubmed]   

52. Sisco M, Kryger ZB, O'Shaughnessy KD, Kim PS, Schultz GS, Ding XZ, et al. Antisense inhibition of connective tissue growth factor (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo. Wound Repair Regen 2008;16:661-673.

http://dx.doi.org/10.1111/j.1524-475X.2008.00416.x

[
Pubmed]   

53. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004;45:4293-4301.

http://dx.doi.org/10.1167/iovs.03-1145

[
Pubmed]   

54. Pflugfelder SC, de Paiva CS, Tong L, Luo L, Stern ME, Li DQ. Stress-activated protein kinase signaling pathways in dry eye and ocular surface disease. Ocul Surf 2005;3(4 Suppl):S154-157.

http://dx.doi.org/10.1016/S1542-0124(12)70244-6


55. Liu W, Wang DR, Cao YL. TGF-beta: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr Gene Ther 2004;4:123-136.

http://dx.doi.org/10.2174/1566523044578004

[
Pubmed]   

56. Liu W, Chua C, Wu X, Wang D, Ying D, Cui L, Cao Y. Inhibiting scar formation in rat wounds by adenovirus-mediated overexpression of truncated TGF-beta receptor II. Plast Reconstr Surg 2005;115:860-870.

http://dx.doi.org/10.1097/01.PRS.0000153037.12900.45

[
Pubmed]   

57. Reid RR, Roy N, Mogford JE, Zimmerman H, Lee C, Mustoe TA. Reduction of hypertrophic scar via retroviral delivery of a dominant negative TGF-beta receptor II. J Plast Reconstr Aesthet Surg 2007;60:64-72.

http://dx.doi.org/10.1016/j.bjps.2005.12.026

[
Pubmed]   

58. Stoff A, Rivera AA, Mathis JM, Moore ST, Banerjee NS, Everts M, et al. Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds. J Mol Med (Berl) 2007;85:481-496.

http://dx.doi.org/10.1007/s00109-006-0148-z

[
Pubmed]   

59. Choi BM, Kwak HJ, Jun CD, Park SD, Kim KY, Kim HR, et al. Control of scarring in adult wounds using antisense transforming growth factor-beta 1 oligodeoxynucleotides. Immunol Cell Biol 1996;74:144-150.

http://dx.doi.org/10.1038/icb.1996.19

[
Pubmed]   

60. Gordon A, Kozin ED, Keswani SG, Vaikunth SS, Katz AB, Zoltick PW, et al. Permissive environment in postnatal wounds induced by adenoviral-mediated overexpression of the anti-inflammatory cytokine interleukin-10 prevents scar formation. Wound Repair Regen 2008;16:70-79.

http://dx.doi.org/10.1111/j.1524-475X.2007.00326.x

[
Pubmed]   

61. Peranteau WH, Zhang L, Muvarak N, Badillo AT, Radu A, Zoltick PW, et al. IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J Invest Dermatol 2008;128:1852-1860.

http://dx.doi.org/10.1038/sj.jid.5701232

[
Pubmed]   

62. Akasaka Y, Ono I, Yamashita T, Jimbow K, Ishii T. Basic fibroblast growth factor promotes apoptosis and suppresses granulation tissue formation in acute incisional wounds. J Pathol 2004;203:710-720.

http://dx.doi.org/10.1002/path.1574

[
Pubmed]   

63. Ono I, Akasaka Y, Kikuchi R, Sakemoto A, Kamiya T, Yamashita T, et al. Basic fibroblast growth factor reduces scar formation in acute incisional wounds. Wound Repair Regen 2007;15:617-623.

http://dx.doi.org/10.1111/j.1524-475X.2007.00293.x

[
Pubmed]   

64. Ono I, Yamashita T, Hida T, Jin HY, Ito Y, Hamada H, et al. Local administration of hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds. J Surg Res 2004;120:47-55.

http://dx.doi.org/10.1016/j.jss.2003.08.242

[
Pubmed]   

65. Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg 1989;84:827-837.

http://dx.doi.org/10.1097/00006534-198911000-00021

[
Pubmed]   

66. Kim DW, Ahn DS. Delayed wound healing and scarring after combined ablative laser and phenol peel treatment. J Plast Reconstr Aesthet Surg 2010;63:e484-485.

http://dx.doi.org/10.1016/j.bjps.2009.09.019

[
Pubmed]   

67. Hartmann B, Ekkernkamp A, Johnen C, Gerlach JC, Belfekroun C, Küntscher MV. Sprayed cultured epithelial autografts for deep dermal burns of the face and neck. Ann Plast Surg 2007;58:70-73.

http://dx.doi.org/10.1097/01.sap.0000250647.39784.bb

[
Pubmed]   

68. Yang J, Woo SL, Yang G, Wang J, Cui L, Liu W, et al. Construction and clinical application of a human tissue-engineered epidermal membrane. Plast Reconstr Surg 2010;125:901-909.

http://dx.doi.org/10.1097/PRS.0b013e3181cc9665

[
Pubmed]   

69. Ueno H, Mori T, Fujinaga T. Topical formulations and wound healing applications of chitosan. Adv Drug Deliv Rev 2001;52:105-115.

http://dx.doi.org/10.1016/S0169-409X(01)00189-2


70. Cho YW, Cho YN, Chung SH, Yoo G, Ko SW. Water-soluble chitin as a wound healing accelerator. Biomaterials 1999;20:2139-2145.

http://dx.doi.org/10.1016/S0142-9612(99)00116-7


71. Ito M, Yang Z, Andl T, Cui C, Kim N, Millar SE, et al. Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature 2007;447:316-320.

http://dx.doi.org/10.1038/nature05766

[
Pubmed]   

72. Hirai Y, Takebe K, Takashina M, Kobayashi S, Takeichi M. Epimorphin: a mesenchymal protein essential for epithelial morphogenesis. Cell 1992;69:471-481.

http://dx.doi.org/10.1016/0092-8674(92)90448-L


73. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29(6 Suppl 16):15-18.

http://dx.doi.org/10.1016/S0093-7754(02)70065-1


74. Heymach JV, Desai J, Manola J, Davis DW, McConkey DJ, Harmon D, et al. Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomas. Clin Cancer Res 2004;10:5732-5740.

http://dx.doi.org/10.1158/1078-0432.CCR-04-0157

[
Pubmed]   

75. Kischer CW. The microvessels in hypertrophic scars, keloids and related lesions: a review. J Submicrosc Cytol Pathol 1992;24:281-296.

[
Pubmed]   

76. Amadeu T, Braune A, Mandarim-de-Lacerda C, Porto LC, Desmoulière A, Costa A. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis. Pathol Res Pract 2003;199:469-473.

http://dx.doi.org/10.1078/0344-0338-00447

[
Pubmed]   

77. Thomas DW, Hopkinson I, Harding KG, Shepherd JP. The pathogenesis of hypertrophic/keloid scarring. Int J Oral Maxillofac Surg 1994;23:232-236.

http://dx.doi.org/10.1016/S0901-5027(05)80377-7


78. Song B, Zhang W, Guo S, Han Y, Zhang Y, Ma F, et al. Adenovirus-mediated METH1 gene expression inhibits hypertrophic scarring in a rabbit ear model. Wound Repair Regen 2009;17:559-568.

http://dx.doi.org/10.1111/j.1524-475X.2009.00514.x

[
Pubmed]   

79. Paquet P, Hermanns JF, Piérard GE. Effect of the 585 nm flashlamp-pumped pulsed dye laser for the treatment of keloids. Dermatol Surg 2001;27:171-174.

http://dx.doi.org/10.1046/j.1524-4725.2001.00169.x

[
Pubmed]   

80. Kawecki M, Bernad-Wiśniewska T, Sakiel S, Nowak M, Andriessen A. Laser in the treatment of hypertrophic burn scars. Int Wound J 2008;5:87-97.

http://dx.doi.org/10.1111/j.1742-481X.2007.00309.x

[
Pubmed]   

81. Cai H, Gu Y, Zeng J, Li SR, Wang Y, Shi DW, et al. [Effect of HMME-PDT on hyperplastic scar in rabbit ear model]. [Article in Chinese]. Zhonghua Zheng Xing Wai Ke Za Zhi 2007;23:425-427.

[
Pubmed]   

82. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, et al. International clinical recommendations on scar management. International Advisory Panel on Scar Management. Plast Reconstr Surg 2002;110:560-571.

http://dx.doi.org/10.1097/00006534-200208000-00031

[
Pubmed]   

83. Kim I, Mogford JE, Witschi C, Nafissi M, Mustoe TA. Inhibition of prolyl 4-hydroxylase reduces scar hypertrophy in a rabbit model of cutaneous scarring. Wound Repair Regen 2003;11:368-372.

http://dx.doi.org/10.1046/j.1524-475X.2003.11509.x

[
Pubmed]   

84. Loladze M, Alibegashvili M, Turmanidze Ts, Iashvili B, Kutivadze D, Chanishvili T. Use of bilidase for the treatment of experimental hypertrophic postburn cicatrices. Bull Exp Biol Med 2005;139:98-100.

http://dx.doi.org/10.1007/s10517-005-0224-3

[
Pubmed]   

85. Rawlins JM, Lam WL, Karoo RO, Naylor IL, Sharpe DT. Pentoxifylline inhibits mature burn scar fibroblasts in culture. Burns 2006;32:42-45.

http://dx.doi.org/10.1016/j.burns.2005.08.004

[
Pubmed]   

86. Dolynchuk KN, Ziesmann M, Serletti JM. Topical putrescine (Fibrostat) in treatment of hypertrophic scars: phase II study. Plast Reconstr Surg 1996;97:117-123.

http://dx.doi.org/10.1097/00006534-199601000-00019

PMid:8532768

This Article Cited By the following articles

Dual delivery of growth factors with coacervate-coated poly(lactic-co-glycolic acid) nanofiber improves neovascularization in a mouse skin flap model
Biomaterials 2017; 124(): 65.

1
 
MicroRNA expression signature and the therapeutic effect of the microRNA-21 antagomir in hypertrophic scarring
2017; 15(3): 1211.

2
 
Unusual ignition of a bullet causing hand injury: Case report
Injury Extra 2014; 45(1): 9-11.

3
 
How to Cite this Article
Pubmed Style

Huseyin Karagoz, Yalcin Bayram, Celalettin Sever, Cihan Sahin, Yalcin Kulahci, Ersin Ulkur. A Review of the Prevention and Treatment of Hypertrophic Scars: Part II. Experimental Studies. Arch Clin Exp Surg. 2013; 2(1): 49-58. doi:10.5455/aces.20120218125115


Web Style

Huseyin Karagoz, Yalcin Bayram, Celalettin Sever, Cihan Sahin, Yalcin Kulahci, Ersin Ulkur. A Review of the Prevention and Treatment of Hypertrophic Scars: Part II. Experimental Studies. http://www.ejmaces.com/?mno=16010 [Access: November 14, 2018]. doi:10.5455/aces.20120218125115


AMA (American Medical Association) Style

Huseyin Karagoz, Yalcin Bayram, Celalettin Sever, Cihan Sahin, Yalcin Kulahci, Ersin Ulkur. A Review of the Prevention and Treatment of Hypertrophic Scars: Part II. Experimental Studies. Arch Clin Exp Surg. 2013; 2(1): 49-58. doi:10.5455/aces.20120218125115



Vancouver/ICMJE Style

Huseyin Karagoz, Yalcin Bayram, Celalettin Sever, Cihan Sahin, Yalcin Kulahci, Ersin Ulkur. A Review of the Prevention and Treatment of Hypertrophic Scars: Part II. Experimental Studies. Arch Clin Exp Surg. (2013), [cited November 14, 2018]; 2(1): 49-58. doi:10.5455/aces.20120218125115



Harvard Style

Huseyin Karagoz, Yalcin Bayram, Celalettin Sever, Cihan Sahin, Yalcin Kulahci, Ersin Ulkur (2013) A Review of the Prevention and Treatment of Hypertrophic Scars: Part II. Experimental Studies. Arch Clin Exp Surg, 2 (1), 49-58. doi:10.5455/aces.20120218125115



Turabian Style

Huseyin Karagoz, Yalcin Bayram, Celalettin Sever, Cihan Sahin, Yalcin Kulahci, Ersin Ulkur. 2013. A Review of the Prevention and Treatment of Hypertrophic Scars: Part II. Experimental Studies. Archives of Clinical and Experimental Surgery (ACES), 2 (1), 49-58. doi:10.5455/aces.20120218125115



Chicago Style

Huseyin Karagoz, Yalcin Bayram, Celalettin Sever, Cihan Sahin, Yalcin Kulahci, Ersin Ulkur. "A Review of the Prevention and Treatment of Hypertrophic Scars: Part II. Experimental Studies." Archives of Clinical and Experimental Surgery (ACES) 2 (2013), 49-58. doi:10.5455/aces.20120218125115



MLA (The Modern Language Association) Style

Huseyin Karagoz, Yalcin Bayram, Celalettin Sever, Cihan Sahin, Yalcin Kulahci, Ersin Ulkur. "A Review of the Prevention and Treatment of Hypertrophic Scars: Part II. Experimental Studies." Archives of Clinical and Experimental Surgery (ACES) 2.1 (2013), 49-58. Print. doi:10.5455/aces.20120218125115



APA (American Psychological Association) Style

Huseyin Karagoz, Yalcin Bayram, Celalettin Sever, Cihan Sahin, Yalcin Kulahci, Ersin Ulkur (2013) A Review of the Prevention and Treatment of Hypertrophic Scars: Part II. Experimental Studies. Archives of Clinical and Experimental Surgery (ACES), 2 (1), 49-58. doi:10.5455/aces.20120218125115





Most Viewed Articles
  • Hirudotherapy /Leech therapy: Applications and Indications in Surgery
    Swaid Abdullah, Latief M. Dar, Adil Rashid, Anita Tewari
    Arch Clin Exp Surg. 2012; 1(3): 172-180
    » Abstract & References » doi: 10.5455/aces.20120402072447

  • Role of Probiotics in Dental Caries and Periodontal Disease
    Amit Bhardwaj, Shalu V Bhardwaj
    Arch Clin Exp Surg. 2012; 1(1): 45-49
    » Abstract & References » doi: 10.5455/aces.20120212100645

  • Use of Polyethylene Fiber (Ribbond) in Pediatric Dentistry
    Eda Arat Maden, Ceyhan Altun
    Arch Clin Exp Surg. 2012; 1(2): 110-115
    » Abstract & References » doi: 10.5455/aces.20120416115640

  • Attenuated familial adenomatous polyposis presenting as an abdominal wall mass
    Marc Paul Jose Lopez, John Paul Senon Gonzalez, Manuel Francisco Tanada Roxas
    Arch Clin Exp Surg. 2017; 6(1): 53-55
    » Abstract » doi: 10.5455/aces.20150809085449

  • Role of Ultrasonography (“Honeycomb Sign”) in Early Detection of Dengue Hemorrhagic Fever
    Sudhir Sachar, Sunder Goyal, Saurabh Sachar
    Arch Clin Exp Surg. 2013; 2(1): 38-42
    » Abstract & References » doi: 10.5455/aces.20120828025157

  • Barium Enema in the Diagnosis of Hirschsprung’s Disease: A Comparison with Rectal Biopsy
    Mohammad Abbas, Arshad Rashid, Asim Rafiq Laharwal, Ajaz Ahmad Wani, Shabir Ahmad Dar, Manzoor Ahamad Chalkoo, Showkat Majeed Kakroo
    Arch Clin Exp Surg. 2013; 2(4): 224-228
    » Abstract & References » doi: 10.5455/aces.20120703031135

  • Long-Term Productive Cough Caused by Tracheal Bronchus
    Chih-Hao Chen, Shih-Yi Lee, Ho Chang, Tzu-Ti Hung
    Arch Clin Exp Surg. 2012; 1(2): 120-121
    » Abstract & References » doi: 10.5455/aces.20120311102403

  • A Review of the Prevention and Treatment of Hypertrophic Scars: Part I Clinical Aspects
    Huseyin Karagoz, Celalettin Sever, Yalcin Bayram, Cihan Sahin, Yalcin Kulahci, Ersin Ulkur
    Arch Clin Exp Surg. 2012; 1(4): 237-248
    » Abstract & References » doi: 10.5455/aces.20120218124923

  • Patient Selection in Plastic Surgery: Recognizing Body Dysmorphic Disorder
    Cihan Sahin, Onat Yilmaz, Yalcin Bayram, Huseyin Karagoz, Celalettin Sever, Yalcin Kulahci, Alpay Ates
    Arch Clin Exp Surg. 2013; 2(2): 109-115
    » Abstract & References » doi: 10.5455/aces.20120722123102

  • Day–Care Surgery for Pilonidal Sinus Using Sinotomy Technique and Fibrin Glue Injection
    Selim Sozen, Vedat Ozturk, Koray Das, Hasan Erdem, Suleyman Cetinkunar, Ilhan Bali
    Arch Clin Exp Surg. 2012; 1(3): 138-141
    » Abstract & References » doi: 10.5455/aces.20120625121721

  • Most Downloaded
  • Attenuated familial adenomatous polyposis presenting as an abdominal wall mass
    Marc Paul Jose Lopez, John Paul Senon Gonzalez, Manuel Francisco Tanada Roxas
    Arch Clin Exp Surg. 2017; 6(1): 53-55
    » Abstract » doi: 10.5455/aces.20150809085449

  • Role of Probiotics in Dental Caries and Periodontal Disease
    Amit Bhardwaj, Shalu V Bhardwaj
    Arch Clin Exp Surg. 2012; 1(1): 45-49
    » Abstract & References » doi: 10.5455/aces.20120212100645

  • Hirudotherapy /Leech therapy: Applications and Indications in Surgery
    Swaid Abdullah, Latief M. Dar, Adil Rashid, Anita Tewari
    Arch Clin Exp Surg. 2012; 1(3): 172-180
    » Abstract & References » doi: 10.5455/aces.20120402072447

  • Patient Selection in Plastic Surgery: Recognizing Body Dysmorphic Disorder
    Cihan Sahin, Onat Yilmaz, Yalcin Bayram, Huseyin Karagoz, Celalettin Sever, Yalcin Kulahci, Alpay Ates
    Arch Clin Exp Surg. 2013; 2(2): 109-115
    » Abstract & References » doi: 10.5455/aces.20120722123102

  • Use of Polyethylene Fiber (Ribbond) in Pediatric Dentistry
    Eda Arat Maden, Ceyhan Altun
    Arch Clin Exp Surg. 2012; 1(2): 110-115
    » Abstract & References » doi: 10.5455/aces.20120416115640

  • Principles of risk management in surgery departments
    Fatemeh Rezaei, Mohammad H Yarmohammadian, Masoud Ferdosi, Abbas Haghshenas
    Arch Clin Exp Surg. 2015; 4(3): 126-134
    » Abstract & References » doi: 10.5455/aces.20140925015830

  • A Study of Methods Used to Reduce Surgical Site Infections
    Stuart R. Walker, Tara Anderson
    Arch Clin Exp Surg. 2012; 1(1): 27-33
    » Abstract & References » doi: 10.5455/aces.20120213053645

  • Slow-Release Drug Deliver System with Polylactic Acid Hydrogels in Prevention of Tracheal Wall Fibroplasia
    Jinrang Li, Lili Peng, Jianjun Sun, Hongguang Guo, Kun Guo, Zuogang Li, Yao Tang, Xu Sun, Shuangqing Zhang
    Arch Clin Exp Surg. 2012; 1(1): 1-7
    » Abstract & References » doi: 10.5455/aces.20120220105531

  • Post-Traumatic Pancreatic Pseudocyst: Report of Two Cases with Review of Literature
    Sunder Goyal, Sudhir Sachar, Ram Kumar Verma, Snigdha Goyal
    Arch Clin Exp Surg. 2013; 2(4): 251-258
    » Abstract & References » doi: 10.5455/aces.20120524103614

  • Role of Ultrasonography (“Honeycomb Sign”) in Early Detection of Dengue Hemorrhagic Fever
    Sudhir Sachar, Sunder Goyal, Saurabh Sachar
    Arch Clin Exp Surg. 2013; 2(1): 38-42
    » Abstract & References » doi: 10.5455/aces.20120828025157

  • Most Cited Articles
  • Hirudotherapy /Leech therapy: Applications and Indications in Surgery
    Swaid Abdullah, Latief M. Dar, Adil Rashid, Anita Tewari
    Arch Clin Exp Surg. 2012; 1(3): 172-180
    » Abstract & References » doi: 10.5455/aces.20120402072447
    Cited : 8 times [Click to see citing articles]

  • Experimental Craniofacial Composite Tissue Allotransplantation (CCTA) Models in Rats
    Yalcin Kulahci, Yalcin Bayram, Huseyin Karagoz, Celalettin Sever, Cihan Sahin
    Arch Clin Exp Surg. 2012; 1(3): 181-187
    » Abstract & References » doi: 10.5455/aces.20120514010906
    Cited : 7 times [Click to see citing articles]

  • Thoracodorsal Artery Perforator Flap: Basic Surgical Determinants
    Celalettin Sever, Yalcin Bayram, Cihan Sahin
    Arch Clin Exp Surg. 2012; 1(4): 270-271
    » Abstract & References » doi: 10.5455/aces.20120506072849
    Cited : 6 times [Click to see citing articles]

  • Pre-expanded Supraclavicular Flap for Post-burn Neck Contractures
    Celalettin Sever, Cihan Sahin
    Arch Clin Exp Surg. 2012; 1(1): 61-62
    » Abstract & References » doi: 10.5455/aces.20120205090034
    Cited : 4 times [Click to see citing articles]

  • Day–Care Surgery for Pilonidal Sinus Using Sinotomy Technique and Fibrin Glue Injection
    Selim Sozen, Vedat Ozturk, Koray Das, Hasan Erdem, Suleyman Cetinkunar, Ilhan Bali
    Arch Clin Exp Surg. 2012; 1(3): 138-141
    » Abstract & References » doi: 10.5455/aces.20120625121721
    Cited : 4 times [Click to see citing articles]

  • The effect of Kristeller maneuver on maternal and neonatal outcome
    Gokhan Acmaz, Evrim Albayrak, Gokalp Oner, Murvet Baser, Gulsum Aykut, Gulender Tas Tekin, Gokmen Zararsiz, Iptisam Ipek Muderris
    Arch Clin Exp Surg. 2015; 4(1): 29-35
    » Abstract & References » doi: 10.5455/aces.20140328024258
    Cited : 4 times [Click to see citing articles]

  • What is the Most Appropriate Animal Model for Experimental Diabetic Neuropathy Studies ?
    Huseyin Karagoz, Mustafa Tansel Kendirli
    Arch Clin Exp Surg. 2012; 1(3): 199-200
    » Abstract & References » doi: 10.5455/aces.20120514012617
    Cited : 3 times [Click to see citing articles]

  • Anesthetic Burns – A Burn Injury Due to A Combination of Local Anaesthetic and Heat Pack
    Stuart Robert Walker
    Arch Clin Exp Surg. 2012; 1(2): 127-128
    » Abstract & References » doi: 10.5455/aces.20120206110836
    Cited : 3 times [Click to see citing articles]

  • A Review of the Prevention and Treatment of Hypertrophic Scars: Part I Clinical Aspects
    Huseyin Karagoz, Celalettin Sever, Yalcin Bayram, Cihan Sahin, Yalcin Kulahci, Ersin Ulkur
    Arch Clin Exp Surg. 2012; 1(4): 237-248
    » Abstract & References » doi: 10.5455/aces.20120218124923
    Cited : 3 times [Click to see citing articles]

  • A Review of the Prevention and Treatment of Hypertrophic Scars: Part II. Experimental Studies
    Huseyin Karagoz, Yalcin Bayram, Celalettin Sever, Cihan Sahin, Yalcin Kulahci, Ersin Ulkur
    Arch Clin Exp Surg. 2013; 2(1): 49-58
    » Abstract & References » doi: 10.5455/aces.20120218125115
    Cited : 3 times [Click to see citing articles]